Messiah University

Mosaic
Biology Educator Scholarship

Biological Sciences

2017

Distinct Parasite Populations Infect Individuals Identified Through
Passive and Active Case Detection in a Region of Declining
Malaria Transmission in Southern Zambia
K. M. Searle
B. Katowa
T. Kobayashi
M. N. S. Siame
S. Mharakurwa

See next page for additional authors
Follow this and additional works at: https://mosaic.messiah.edu/bio_ed
Part of the Biology Commons

Permanent URL: https://mosaic.messiah.edu/bio_ed/156
Recommended Citation
Searle, K. M.; Katowa, B.; Kobayashi, T.; Siame, M. N. S.; Mharakurwa, S.; Carpi, G.; Norris, D. E.; Stevenson,
J. C.; Thuma, Philip; and Moss, W. J., "Distinct Parasite Populations Infect Individuals Identified Through
Passive and Active Case Detection in a Region of Declining Malaria Transmission in Southern Zambia"
(2017). Biology Educator Scholarship. 156.
https://mosaic.messiah.edu/bio_ed/156

Sharpening Intellect | Deepening Christian Faith | Inspiring Action
Messiah University is a Christian university of the liberal and applied arts and sciences. Our mission is to educate
men and women toward maturity of intellect, character and Christian faith in preparation for lives of service,
leadership and reconciliation in church and society.
www.Messiah.edu

One University Ave. | Mechanicsburg PA 17055

Authors
K. M. Searle, B. Katowa, T. Kobayashi, M. N. S. Siame, S. Mharakurwa, G. Carpi, D. E. Norris, J. C.
Stevenson, Philip Thuma, and W. J. Moss

This article is available at Mosaic: https://mosaic.messiah.edu/bio_ed/156

Malaria Journal

Searle et al. Malar J (2017) 16:154
DOI 10.1186/s12936-017-1810-3

Open Access

RESEARCH

Distinct parasite populations infect
individuals identified through passive
and active case detection in a region
of declining malaria transmission in southern
Zambia
Kelly M. Searle1*, Ben Katowa2, Tamaki Kobayashi1, Mwiche N. S. Siame2, Sungano Mharakurwa3,
Giovanna Carpi4, Douglas E. Norris4, Jennifer C. Stevenson2,4, Philip E. Thuma2,4, William J. Moss1,4 and for the
Southern Africa International Centers of Excellence for Malaria Research

Abstract
Background: Substantial reductions in the burden of malaria have been documented in parts of sub-Saharan Africa,
with elimination strategies and goals being formulated in some regions. Within this context, understanding the
epidemiology of low-level malaria transmission is crucial to achieving and sustaining elimination. A 24 single-nucleotide-polymorphism Plasmodium falciparum molecular barcode was used to characterize parasite populations from
infected individuals identified through passive and active case detection in an area approaching malaria elimination
in southern Zambia.
Methods: The study was conducted in the catchment area of Macha Hospital in Choma District, Southern Province,
Zambia, where the parasite prevalence declined over the past decade, from 9.2% in 2008 to less than 1% in 2013.
Parasite haplotypes from actively detected, P. falciparum-infected participants enrolled in a serial cross-sectional,
community-based cohort study from 2008 to 2013 and from passively detected, P. falciparum-infected individuals
enrolled at five rural health centres from 2012 to 2015 were compared. Changes in P. falciparum genetic relatedness,
diversity and complexity were analysed as malaria transmission declined.
Results: Actively detected cases identified in the community were most commonly rapid diagnostic test negative,
asymptomatic and had submicroscopic parasitaemia. Phylogenetic reconstruction using concatenated 24 SNP barcode revealed a separation of parasite haplotypes from passively and actively detected infections, consistent with two
genetically distinct parasite populations. For passively detected infections identified at health centres, the proportion
of detectable polyclonal infections was consistently low in all seasons, in contrast with actively detected infections in
which the proportion of polyclonal infections was high. The mean genetic divergence for passively detected infections was 34.5% for the 2012–2013 transmission season, 37.8% for the 2013–2014 season, and 30.8% for the 2014–
2015 season. The mean genetic divergence for actively detected infections was 22.3% in the 2008 season and 29.0%
in the 2008–2009 season and 9.9% across the 2012–2014 seasons.
Conclusions: Distinct parasite populations were identified among infected individuals identified through active
and passive surveillance, suggesting that infected individuals detected through active surveillance may not have
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contributed substantially to ongoing transmission. As parasite prevalence and diversity within these individuals
declined, resource-intensive efforts to identify the chronically infected reservoir may not be necessary to eliminate
malaria in this setting.
Keywords: Malaria elimination, Molecular barcode, Parasite genetics, Molecular epidemiology, Population genetics,
Zambia, Sub-Saharan Africa

Background
Substantial reductions in the burden of malaria have
been documented in parts of sub-Saharan Africa [1] and
malaria elimination goals have been proposed at regional,
national, and subnational levels [2–4]. As areas transition from high or moderate to low malaria transmission
and approach elimination, understanding the epidemiology of low-level transmission is crucial to achieving and
sustaining elimination [2, 3, 5]. The relative magnitude
of infection attributed to locally acquired and imported
cases is of interest, specifically the role of the chronically
infected, asymptomatic reservoir in maintaining local
malaria transmission [6–10]. One way to address this
question is to determine the genetic relatedness of parasites between actively detected, predominantly chronically infected, asymptomatic individuals and passively
detected, predominantly acutely infected, symptomatic
malaria cases [11]. By comparing the genetic overlap
between parasites infecting these populations, inferences
can be made regarding the relative contribution of the
asymptomatic reservoir to symptomatic malaria cases.
Understanding the role of these two populations in local
malaria transmission dynamics can guide interventions,
particularly reactive case detection and focal or mass
drug administration strategies that target the chronically
infected, asymptomatic reservoir.
A Plasmodium falciparum molecular barcode assay
consisting of 24 unlinked, single nucleotide polymorphisms (SNPs) has been used to characterize unique
genetic signatures and track circulating P. falciparum
parasite populations [11]. The barcode was developed
to elucidate malaria transmission dynamics by tracking the genetic diversity and complexity of the parasite
over time and space [12–14], and specifically for use in
resource-limited settings as the highest level of technology required is a polymerase chain reaction (PCR) assay
[11].
This study was conducted in an area of southern Zambia that experienced a dramatic decrease in malaria
transmission over the past decade [15]. The molecular
barcode was used to determine the relatedness between
parasites over time in infected individuals identified
through passive and active surveillance from the same
geographic area, as well as changes in parasite genetic
complexity and diversity.

Methods
Study site and population

The study was conducted in the catchment area of Macha
Hospital in Choma District, Southern Province, Zambia, where there is a single rainy season which lasts from
November through April, followed by a cool dry season from April until August and a hot dry season from
August through November. Malaria transmission peaks
during the rainy season [16] and the primary vector is
Anopheles arabiensis [16, 17]. The hospital catchment
area is approximately 1200 km2 with roughly 30,000
residents consisting primarily of villagers living in small,
scattered homesteads. The prevalence of P. falciparum
infection declined in this area over the past decade, from
9.2% in 2008 to less than 1% in 2013 [18]. Artemisininbased combination therapy (ACT) with artemether–
lumefantrine was introduced as first-line anti-malarial
therapy in Zambia in 2002 [19] and into the study area
in 2004. In Zambia, long-lasting insecticide-treated nets
(LLINs) are distributed through antenatal care clinics
and additional mass distribution campaigns [20]. LLINs
were widely distributed in the study area in 2007 [21]
and more than 11,000 LLINs were distributed from nine
health posts in the catchment area of Macha Hospital
in June 2012, with additional LLINs distributed in 2014
according to the Office of the Macha Hospital Environmental Health Technician. ITN ownership was estimated
at 83% in the study area in 2013 [15].
Active community‑based malaria surveillance

Satellite images were used to develop a sampling frame
for the random selection of households to enroll participants in longitudinal and cross-sectional malaria surveys
[21]. The identification and enumeration of households
was done manually to delineate household and nonhousehold structures (kraals, schools, and larger structures) [21]. Households selected from the sampling frame
were enrolled in either a cross-sectional or longitudinal cohort. Households enrolled in the cross-sectional
cohort were surveyed once, whereas households enrolled
in the longitudinal cohort were repeatedly surveyed every
2 months. Surveys were conducted each month, alternating between the cross-sectional cohort and the longitudinal cohort, from February 2008 through October 2013.
For each study visit, a questionnaire was administered
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to collect demographic data, history of recent malaria
symptoms and treatment, healthcare-seeking behaviour,
knowledge of malaria risk and prevention, and longlasting insecticidal net use. Recent malaria symptoms
were defined as having a documented fever greater than
38 °C by tympanic temperature, or reporting a fever and
chills within the previous 48 h. A blood sample was collected by finger prick for a rapid diagnostic test (RDT),
microscopy and blood was spotted on Whatman 903™
Protein Saver cards. These dried blood spots (DBS) were
used to detect Plasmodium parasites by a nested PCR as
described below and molecular barcoding was attempted
for all samples positive for Plasmodium parasites by
nested PCR (Additional file 1: Figure S1). Participants
positive by RDT were offered treatment with artemetherlumefantrine (Coartem®).
Passive malaria surveillance at rural health centres

Fourteen rural health centres (RHCs) that serve the
catchment population surrounding Macha Hospital sent
a weekly text message report of the number of RDTs
used, number of positive RDTs, and the number of people treated for malaria to study staff at Macha Research
Trust [22]. Five of these RHCs within the study area
where active surveillance was conducted were included
in a sub-study from 2012 through 2015 that collected
DBS from a convenience sample of individuals with a
positive RDT and recorded their demographic data.
Molecular barcoding was attempted for all samples collected at the RHCs (Additional file 1: Figure S1).
Laboratory methods

The DBS were stored at −20 °C in individual plastic bags
containing desiccant until DNA extraction. DBS collected from February to September 2008 were initially
stored at room temperature and subsequently at −20 °C.
Parasite DNA was extracted using the Chelex© method
from one dried blood spot [18]. Briefly, the DBS were
placed in 1.5 mL microcentrifuge tubes, 1 mL of 0.1%
weight by volume saponin in 1× phosphate buffered
saline (PBS) was added and the mixture was incubated
for 10 min at room temperature. The tubes were centrifuged for 2 min at 14,000 rpm, the supernatant discarded
and 1 mL of 1× PBS was added. The tubes were again
centrifuged for 2 min at 14,000 rpm, the supernatant discarded and 150 μL of 2% weight by volume Chelex© solution and 50 μL of DNase free water were added and the
tubes were boiled for 8 min. The tubes were then centrifuged for 1 min at 14,000 rpm and approximately 150 μL
of DNA was stored at −20 °C.
Infection was confirmed using a Plasmodium multispecies nested PCR assay as previously described [18, 23]
targeting a 815 base-pair segment of the mitochondrial
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cytochrome b gene (cytb). Briefly, in the primary PCR
step, 6 μL of DNA extract was added to 0.2 mL tubes containing a 19 μL reaction mix made up of DNase free water
and final concentrations of 200 μM dNTPs, 1× ThermoPol PCR buffer (New England Biolabs, Ipswich, MA,
USA), 1 μM forward and 1 μM reverse primers and DNA
Taq polymerase (New England Biolabs, Ipswich, MA)
in 25 μL reaction volume. In the nested PCR step, 3 μL
of the primary PCR product was added to 0.2 mL PCR
tubes containing 22 μL of reaction mix with DNase free
water and the final concentrations of dNTPs, Thermopol
buffer, forward and reverse primers, and Taq DNA polymerase in a 25 μL reaction mix as described above. No
template controls were included in each experiment and
reactions were run in a Techne™ TC-412 thermo cycler
(Bibby Scientific Limited, Staffordshire, UK). Amplified
product was detected by electrophoresis on 1% agarose
gel and viewed under UV light.
The 24 SNP molecular barcode assays were run using
a TaqMan protocol at the Macha Research Trust laboratory in Zambia [11]. DNA was extracted from a second
dried blood spot for samples positive by nested PCR
using the Chelex© method. Due to low parasite DNA
concentrations, samples were pre-amplified prior to performing the 24 SNP molecular barcode assay [24]. The
pre-amplification step was done by adding 5 μL of DNA
from each sample to 10 μL of TaqMan pre-amplification
master mix, and 0.2× pooled assay mixture, containing
of forward and reverse primers for each of the 24 SNPs as
previously described [24].
Pre-amplified samples were diluted 1:20 with TE buffer
prior to running the 24 SNP molecular barcoding assay
as previously described [24]. For each of the 24 SNP
assays, 2.0 μL of pre-amplified sample DNA was added
to 10 μL of TaqMan master mix, 7.5 μL distilled water,
and 0.5 μL TaqMan commercially available primer and
probe assay mixture. For each assay, three known positive controls and two negative, no-template controls were
run. Positive controls consisted of DNA samples from P.
falciparum strains obtained from MR4 (now known as
BEI Resources, Manassas, VA, USA) with known haplotypes for all 24 SNPs. Typically, 12 SNP assays were run
for five samples at a time with controls on a 96-well plate.
The assays were run on the Applied Biosystems StepOnePlus™ (Thermo Scientific, Waltham, MA, USA), and the
Roche LightCycler 480™ (Roche Diagnostics Corporation, Indianapolis, IN, USA) real time PCR systems.
Parasites sampled from peripheral blood are those in
the haploid intra-erythrocytic stage of their lifecycle. [11].
Thus, SNP calls were made automatically based on allelic
discrimination plots using software programs accompanying the real time PCR systems as one of the two alleles
or mixed [25, 26]. In cases where SNP calls could not be
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made automatically, determination was made manually by
the study investigators. Otherwise the SNP call was classified as failed. Samples with failed SNP calls were repeated
up to three times. If a sample failed on all repeated assays,
the SNP was treated as missing data.
Phylogenetic analysis

Haplotypes, composed of the concatenated 24 SNPs,
were aligned using the ClustalW method in MEGA6
software, with mixed calls represented as a third possible
allele [13]. Phylogenetic analyses were conducted using
the maximum likelihood methods for actively and passively detected malaria infections separately, grouped by
malaria transmission season, to explore temporal phylogenetic clustering of haplotypes. Haplotypes for the combined dataset were aligned using the same method and
a phylogenetic tree was constructed using the maximum
likelihood method.
Parasite genetic complexity and diversity

Parasite genetic complexity was determined by the number of mixed calls at each of the 24 SNPs. Samples with
four or more mixed calls were categorized as polyclonal
infections [27]. Temporal trends were graphed and variation in the proportion of polyclonal infections was determined using the Wilcoxon rank-sum test. Samples with
more than half missing data were excluded (eight samples
from active surveillance and seven samples from passive
surveillance).
Parasite genetic diversity was evaluated by determining divergence from the most common barcode for each
transmission season stratified by whether the parasite
was identified through passive or active surveillance. The
most common barcode for each season was determined
by allelic frequency at each SNP to determine the nucleotide diversity. A modified ‘SNP π’, was developed to
account for missing data and mixed allele calls, and was
used to measure the seasonal parasite genetic divergence
[14]. Details of the methods for calculating the modified
‘SNP π’ are described in the Additional file 2: Appendix.
Statistical analyses

Data on age and sex analysed for passively detected cases.
Age, sex, symptoms of malaria, and RDT and microscopy
results were analysed for actively detected cases. Median
ages between actively and passively detected infected
individuals and across transmission seasons were compared using a Kruskal–Wallis test. Sex differences
between groups and across transmission seasons were
compared using a c hi2 test. RDT and microscopy results
across transmission seasons were compared for actively
detected cases using a chi2 test.
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Results
The 24 SNP molecular barcode was performed on
72 samples from actively detected malaria cases collected from 2008 to 2013 and 46 samples from passively
detected malaria cases collected from 2012 to 2015.
Households of actively detected cases and the RHC from
which the passively detected cases were identified came
from the same underlying source population (Fig. 1).
The median age was 13 years (IQR = 7–30) for infected
individuals identified through passive case detection
and 14 years (IQR = 11–21) for those identified through
active case detection (p = 0.63) (Table 1). There were
no statistically significant differences in sex between the
two study populations (p = 0.34), and no statistically significant differences in median age or sex were observed
in passively (p = 0.15, p = 0.63 respectively) or actively
(p = 0.79, p = 0.96 respectively) detected cases across
the malaria transmission seasons (Table 1). While all
actively detected cases were identified by PCR, no statistically significant differences were observed in microscopy results across the malaria transmission seasons
(p = 0.07), with most infected individuals detected by
active case detection negative by microscopy (Table 1).
Statistically significant differences were observed in
the RDT results across malaria transmission seasons
(p = 0.001), with the proportion of RDT positive infections variable, but all seasons had a higher proportion
of RDT negative infections among individuals identified through active surveillance (Table 1). Statistically
significant differences were observed in the proportion
of individuals reporting symptoms of malaria for each
season (p = 0.02), with trends in symptomatic infections
decreasing from the 2008 season through the 2010–2011
season, then subsequently increasing (Table 1). For both
actively and passively detected malaria cases, no identical molecular barcodes were detected and all haplotypes
were unique.
Phylogenetic trees

The phylogenetic tree showed evidence of clustering
of haplotypes from passively detected cases during the
2012–2013 annual malaria transmission season along
with some mixing during the other two seasons (Fig. 2a).
However, there was no evidence of phylogenetic clustering during the 2013–2014 and 2014–2015 annual malaria
transmission seasons (Fig. 2a). For actively detected
cases, the phylogenetic tree showed no evidence of phylogenetic clustering during any of the malaria transmission seasons (Fig. 2b). In a combined phylogenetic tree,
parasite haplotypes from passively and actively detected
cases were largely divergent (Fig. 3), suggesting two
genetically distinct parasite populations (Fig. 3).
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Fig. 1 Map of the study area displaying locations of RHCs included in passive malaria surveillance and households of infected individuals included
in active community-based malaria surveillance

Table 1 Demographic characteristics of passively and actively detected individuals infected with Plasmodium falciparum
by malaria transmission season
Overall

2008a

2008–2009 2009–2010 2010–2011

2011–2012 2012–2013 2013–2014 2014–2015

Number

46

–

–

–

–

–

12

25

9

Age in years (median
[IQR])

13 [7–30]

–

–

–

–

–

11 [7–30]

18 [9–32]

11 [7–11]

Male (%)

64.4

–

–

–

–

–

63.64

60.00

77.78

72

15

19

7

6

Passively detected cases

Actively detected cases
Number

a

13

12

Age in years (median
[IQR])

14 [11–21] 14 [9–18] 13 [11–18]

17 [11–20]

14.5 [10.5–24] 25 [13–31]

12.5 [6–47]

Male (%)

55.6

66.7

52.6

53.9

50.0

57.1

50.0

Symptomatic (%)

34.7

60.0

15.8

23.1

16.7

57.1

66.7

Microscopy positive (%)

11.1

35.0

7.1

11.1

0.0

25.0

0.0

RDT positive (%)

20.8

20.0

31.6

23.1

8.3

14.3

16.7

The 2008 season was truncated as active case detection began in February 2008

Genetic complexity and diversity

Genetic complexity was approximated by calculating the
proportion of polyclonal infections in a transmission season. The proportion of polyclonal infections was consistently low for passively detected cases in all seasons, with
no polyclonal infections identified during the 2012–2013

and 2014–2015 annual transmission seasons (Table 2;
Fig. 4a). In contrast, the proportion of polyclonal infections among actively detected cases was consistently high
for all malaria transmission seasons (Fig. 4b). The last
two seasons were combined due to the low numbers of
cases but all infections were polyclonal (Table 2; Fig. 4b).
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Fig. 2 Phylogenetic trees of a passively detected infections and b actively detected infections, by malaria transmission season

This decreased to 9.9% in the combined 2012–2014 seasons (Table 2; Fig. 5b). Overall, the genetic divergence
remained high among passively detected cases but
decreased for actively detected cases (Fig. 5b).

Fig. 3 Phylogenetic tree of actively and passively detected infections

No seasonal trends in genetic complexity were identified
(Fig. 4b).
The mean genetic divergence for passively detected
cases was 34.5% for the 2012–2013 season, 37.8% for
the 2013–2014 season, and 30.8% for the 2014–2015
season (Table 2; Fig. 5a). The mean genetic divergence
for actively detected cases was 22.3% in the 2008 season
and 29.0% in the 2008–2009 season (Table 2; Fig. 5b).

Discussion
Distinct parasite populations were found in individuals identified through passive and active surveillance in
a region of declining malaria transmission in southern
Zambia using a SNP-based molecular barcode for P. falciparum. These results suggest that the population of
mostly asymptomatic, actively detected infections may
not significantly contribute to ongoing transmission in
this setting and may not be the primary source of infection leading to clinical malaria cases.
The molecular barcode can be used to document parasite diversity over time by providing information on the
number of unique barcodes present each year, the persistence of unique barcodes between years, and the genetic
divergence measured by nucleotide diversity within
and between years. The molecular barcode determines
whether the major allele, minor allele, or a mixture of
major and minor alleles is present in the haploid blood
stage of the parasite infection for each of the 24 SNPs.
The resulting barcode represents the parasite’s haplotype and can be used to compare the genetic relatedness
between individual (monoclonal and polyclonal) infections and populations of parasites infecting different
communities [28]. Variation arises as a result of genetic
recombination and outcrossing during the sexual stage
of infection in the mosquito vector when gametocytes
combine [13]. SNPs with a mixture of major and minor
alleles are referred to as mixed (polyclonal) infections,
with higher numbers of mixed infections representing
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Table 2 Percent of polyclonal infections and genetic divergence for passively and actively detected individuals infected
with Plasmodium falciparum by malaria transmission season
Number

Percent polyclonal (95% Confidence interval)

Percent genetic divergence (95% Confidence interval)

Passively detected cases
2012–2013

12

0 (0–26)

35 (27–42)

2013–2014

25

12 (3–31)

38 (34–42)

2014–2015

9

0 (0–34)

31 (19–43)

Actively detected cases

a

2008a

15

87 (60–98)

22 (17–28)

2008–2009

19

79 (54–94)

29 (26–32)

2009–2010

13

69 (39–91)

24 (20–28)

2010–2011

12

92 (62–100)

15 (10–19)

2011–2012

7

86 (42–100)

18 (11–26)

2012–2014

6

100 (54–100)

10 (2–17)

The 2008 season was truncated as active case detection began in February 2008

Fig. 4 Proportion of polyclonal infections by season for a passively detected infections and b actively detected infections

Fig. 5 Mean genetic divergence by season for a passively detected infections and b actively detected infection
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higher genetic complexity. The frequency of mixed infections approximates the level of genetic complexity and
provides information about the burden of infection due
to genetically unique parasites [27].
Typically, as malaria transmission declines, a genetic
bottleneck is created, reducing opportunities for outcrossing in the mosquito midgut and leading to reduced
parasite diversity among passively detected, symptomatic malaria cases [13, 28]. This decline in diversity is
accompanied by a decline in the complexity of infection, as fewer unique parasites circulate in the population [13, 28]. However, parasite diversity among passively
detected, symptomatic infections did not decline in
southern Zambia and the complexity of infection was
low. As malaria transmission was consistently low
between the 2012 and 2015 seasons, the sustained, high
parasite diversity in symptomatic infections may be evidence of imported malaria with subsequent local transmission among individuals susceptible to clinical malaria.
Passively detected cases also had fewer complex infections, with a low proportion of polyclonal infections, consistent with recent infection with single parasite clones. In
contrast, actively detected cases had more complex infections, with a high proportion of polyclonal infections.
Between the 2008 and 2009–2010 transmission seasons
there was an indication of a non-statistically significant,
decreasing trend in the proportion of polyclonal infections; however, this proportion subsequently increased
and remained high, indicating that the actively detected
population of mostly asymptomatic and sub-patent infections was composed of many different parasite clones.
While transmission declined, these individuals may have
harboured parasites acquired over time and maintained at
low levels of parasitaemia. Chronic infections have been
shown to persist for up to a decade [29–32].
Parasite genetic diversity remained relatively high
and constant for passively detected cases throughout
the observed malaria transmission seasons. This finding, along with the phylogenetic separation from actively
detected cases and the paucity of detectable polyclonal
infections, suggests these passively detected cases may
represented recent infections with parasites imported
into the study area. In contrast, parasite genetic diversity
was lower among actively detected cases, consistent with
a chronically infected population. The decreasing parasite
diversity among the actively detected cases over the study
period is consistent with loss of parasites from this chronically infected reservoir as malaria transmission declined.
Previous studies using this genotyping approach were
reported from Senegal and Malawi. The molecular barcode was used in Senegal to determine the clonal and
epidemic expansion of passively detected clinical P. falciparum infections [13]. After enhanced deployment of
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ITNs and use of RDTs and ACT between 2005 and 2011,
reductions in parasite genetic diversity and complexity
were observed [13]. Between 2006 and 2013, the molecular barcode was used to determine the decline in malaria
transmission among passively detected infections, with
re-introduction in 2012 [28]. In Malawi, the molecular
barcode was used to determine differences in the complexity of infection between severe clinical malaria cases
and cerebral malaria cases among children younger than
5 years of age [27]. Children with cerebral malaria had less
complex infections than those with severe malaria [27]. To
the authors’ knowledge, this is the first time this molecular barcode was used to determine the genetic relatedness
between actively and passively detected infections.
Analyses of spatial hotspots of asymptomatic parasitemia and clinical malaria cases have been previously
published from low and moderate transmission settings
in Kenya and Mali [32–35]. In the Kenya studies, no spatial overlap was identified between hotspots of asymptomatic malaria infections and clinical malaria infections
[33, 34]. This spatial disaggregation supports the hypothesis that the asymptomatic reservoir may not be the
major source of infection leading to clinical malaria in
low transmission settings. The parasite prevalence in the
Macha study area is lower than reported in the Kenya
studies. The genetic separation of parasites infecting the
asymptomatic and symptomatic populations identified
in the current study provides additional support that
as areas approach elimination the chronically infected
population may not contribute substantially to ongoing
transmission and a high proportion of clinical cases are
likely due to seasonal importation. This has important
implications for the need for resource-intensive efforts to
identify and treat the chronically-infected, asymptomatic
reservoir through reactive test-and-treat strategies, focal
or mass drug administration, or using highly sensitivity
diagnostic tests.
There were several major limitations of these analyses. The first was that passive and active case detection
did not overlap in time except for one malaria transmission season. However, given the absence of seasonal
phylogenetic clustering for both passively and actively
detected cases, and because all samples came from the
same underlying source population, the combined phylogenetic tree is likely an accurate representation of the
phylogenetic relationships between the two parasite populations. Additionally, when constructing the combined
phylogenetic tree, samples were indexed by season so
within season relationships between the two populations
would not be masked. The second limitation was the high
number of mixed infections from which single haplotypes were difficult to resolve. To account for this, a third
allele was used to indicate mixed infections in calculating
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the phylogenetic relatedness and mixed infections were
accounted for when calculating genetic divergence [13,
14]. The third limitation was that the sample size was
relatively small, although this is to be expected in a preelimination setting. The fourth limitation was the low
level of parasitaemia, also an expected finding in a preelimination setting. Pre-amplification of parasite DNA
was performed to increase the molecular barcode yield
but potentially introduced bias in the allele frequency.
However, pre-amplification sites were barcode specific to
reduce amplification in non-specific parasite DNA, and
all samples were pre-amplified regardless of level of parasitaemia [24]. After pre-amplification, assays with greater
than three failures were treated as missing data and samples with over half of data missing were dropped from
analyses. However, missing data may have been informative as these samples had low levels of parasitaemia.

Conclusions
Distinct parasite populations were found among infected
individuals identified through active and passive surveillance in a low transmission setting in southern Zambia.
The actively detected population represented a chronically infected, reservoir that may not contribute substantially to ongoing transmission. As parasite prevalence
and diversity within the actively detected cases declined
over time, resource-intensive efforts to identify and treat
the chronically infected reservoir through reactive case
detection, or focal or mass drug administration, may not
be necessary to eliminate malaria in this setting.
Additional files
Additional file 1. Flow diagram of sample selection.
Additional file 2. The modified ‘SNP π’ used to account for missing data
and mixed allele calls was calculated as follows.
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